Current Pharmaceutical Design
Title: Editorial [Drugs Promoting Wakefulness and Performance Executive Editor: J.G. Ramaekers]
Volume: 12 Issue: 20
Author(s): J. G. Ramaekers
Affiliation:
Export Options
About this article
Cite this article as:
Ramaekers G. J., Editorial [Drugs Promoting Wakefulness and Performance Executive Editor: J.G. Ramaekers], Current Pharmaceutical Design 2006; 12 (20) . https://dx.doi.org/10.2174/138161206777698846
DOI https://dx.doi.org/10.2174/138161206777698846 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
8
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Updates in the Medical Management of Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Depression and Medication Adherence in Patients on Hemodialysis
Current Hypertension Reviews The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases
Current Pharmaceutical Design Molecular Interaction of the Antineoplastic Drug, Methotrexate with Human Brain Acetylcholinesterase: A Docking Study
CNS & Neurological Disorders - Drug Targets Physiological and Non-Redundant Functions of PKC Isotypes in T Lymphocytes
Current Immunology Reviews (Discontinued) Weaning and Extubation in Pediatrics
Current Respiratory Medicine Reviews Preface [Hot Topic: Monoamine Oxidase (MAO) Research (Guest Editor: K. Magyar)]
Current Medicinal Chemistry Exposure to Enriched Environment Restores the mRNA Expression of Mineralocorticoid and Glucocorticoid Receptors in the Hippocampus and Ameliorates Depressive-like Symptoms in Chronically Stressed Rats
Current Neurovascular Research Roles of Cannabidiol in the Treatment and Prevention of Alzheimer’s Disease by Multi-target Actions
Mini-Reviews in Medicinal Chemistry Quantitative Structure-Activity Relationship (QSAR) Analysis to Predict Drug-Drug Interactions of ABC Transporter ABCG2
Mini-Reviews in Medicinal Chemistry Diabetes of the Brain: Computational Approaches and Interventional Strategies
CNS & Neurological Disorders - Drug Targets Role of Melatonin in the Inflammatory Process and its Therapeutic Potential
Current Pharmaceutical Design Pharmacokinetics of Ceftriaxone in Carbontetrachloride-Induced Hepatopathic and Uranyl nitrate-Induced Nephropathic Goats Following Single Dose Intravenous Administration
Drug Metabolism Letters Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs
Current Drug Therapy Diminished Renal Function and the Incidence of Heart Failure
Current Cardiology Reviews Editorial
Current Psychiatry Reviews Recent Technological Advances in the Mass Spectrometry-based Nanomedicine Studies: An Insight from Nanoproteomics
Current Pharmaceutical Design Cordycepin Exerts Neuroprotective Effects via an Anti-Apoptotic Mechanism based on the Mitochondrial Pathway in a Rotenone-Induced Parkinsonism Rat Model
CNS & Neurological Disorders - Drug Targets Protein Engineering: A New Frontier for Biological Therapeutics
Current Drug Metabolism Epidemiology of Psychotic Symptoms during Pregnancy and Postpartum in Women with Schizophrenia
Current Women`s Health Reviews